JPMorgan Equity Premium Income ETF Sees Inflows Amid Decline

JPMorgan Equity Premium Income ETF ( $JEPI ) has fallen by 1.82% in the past week. It has experienced a 5-day net inflow of $280.93 million.
This is due, in part, to market sentiment on some of the ETF’s largest holdings. For example:

• EOG Resources Inc drew a flurry of cautious analyst attention, with J.P. Morgan, TD Cowen, Barclays and others reiterating Hold ratings and price targets around $140–$146, even as some prior targets were raised. The stock is up strongly year‑to‑date and viewed as a top‑tier shale producer with solid cash flow, but insider selling, softer year‑on‑year profits and heavy options hedging ahead of April earnings signal limited near‑term upside and higher volatility.
• Johnson & Johnson remains a steady healthcare bellwether, as Morgan Stanley reaffirmed a Buy rating with a $262 target, above the roughly $235 recent close. The broader analyst consensus is a Moderate Buy with about 8% upside, supported by a strengthening growth story in immunology, positive sentiment around new drug approvals and a history of resilient earnings that appeals to defensive, long‑term investors.
• Ross Stores continued to impress the Street after a strong holiday quarter, with revenue, earnings and same‑store sales comfortably beating expectations and driving the shares higher. Analysts at Bank of America, Telsey and others largely rate the stock a Buy with targets near $236–$244, citing secular demand for off‑price retail and solid guidance, though notable insider selling and a richer valuation temper the otherwise bullish outlook.